跳至主要内容
临床试验/ACTRN12612000559819
ACTRN12612000559819招募中未知

Pharmacokinetic modelling of antibiotic, sedative and analgesic drugs and their relevant metabolites in critically ill patients receiving extracorporeal membrane oxygenation (ECMO) and development of dosing guidelines to optimise drug therapy during ECMO.

Critical Care Research Group0 个研究点目标入组 160 人开始时间: 2012年5月25日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 89 Years(—)
性别
All

入选标准

  • Currently undergoing ECMO for respiratory +/- cardiac dysfunction
  • - Clinical indication for the antibiotics ceftriaxone, cefepime, meropenem, gentamicin, ciprofloxacin, ticarcillin-clavulanate, piperacillin-tazobactum, vancomycin, linezolid, caspofungin, fluconazole, voriconazole and oseltamivir
  • - Clinical indication for the sedatives and analgesics morphine, fentanyl, midazolam, dexmedetomidine, propfol or thiopentone

排除标准

  • - No valid consent
  • - Known allergy to study drug
  • - Pregnancy
  • - S. Bilirubin >150
  • - Ongoing massive blood loss and blood product transfusion
  • - Therapeutic plasma exchange in the last 24 hours.

研究者

相似试验